AlphaCentric Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$2.28M Buy
2024
Q2
$1.36M Buy
2024
Q1
$1.35M Buy
2023
Q4
$1.35M Sell
2023
Q3
$1.46M Hold
2023
Q2
$1.43M Buy
2023
Q1
$535K Buy
2021
Q4
$839K Buy
2021
Q3
$618K Hold
2021
Q2
$668K Hold
2021
Q1
$604K Buy
2020
Q4
$658K Buy
2020
Q3
$171K Buy